Stephen Jay Frank

1.7k total citations
26 papers, 227 citations indexed

About

Stephen Jay Frank is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stephen Jay Frank has authored 26 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stephen Jay Frank's work include Prostate Cancer Treatment and Research (13 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Medical Imaging Techniques and Applications (4 papers). Stephen Jay Frank is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Medical Imaging Techniques and Applications (4 papers). Stephen Jay Frank collaborates with scholars based in Israel, United States and Finland. Stephen Jay Frank's co-authors include Michal Lotem, Tamar Peretz, Sharon Merims, Eli Rosenbaum, Daniel Keizman, Jonathan Cohen, Avivit Peer, Ofer N. Gofrit, Mordechai Duvdevani and Vladimir Yutkin and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Advances in experimental medicine and biology.

In The Last Decade

Stephen Jay Frank

24 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Jay Frank Israel	9	116	107	81	46	42	26	227
Steven Hazell United Kingdom	7	123 1.1×	79 0.7×	39 0.5×	35 0.8×	49 1.2×	13	228
Daan De Maeseneer Belgium	10	95 0.8×	109 1.0×	24 0.3×	84 1.8×	27 0.6×	23	228
Florestan Koll Germany	9	87 0.8×	80 0.7×	32 0.4×	97 2.1×	27 0.6×	38	214
D Jacqmin United States	8	112 1.0×	87 0.8×	89 1.1×	65 1.4×	48 1.1×	19	286
Rana Harb United States	7	152 1.3×	116 1.1×	17 0.2×	24 0.5×	63 1.5×	9	211
M.D. Mason United Kingdom	6	254 2.2×	42 0.4×	41 0.5×	31 0.7×	40 1.0×	9	367
Claude Chahine France	7	29 0.3×	128 1.2×	38 0.5×	21 0.5×	19 0.5×	21	176
Masakazu Doi Japan	5	45 0.4×	54 0.5×	22 0.3×	192 4.2×	12 0.3×	10	322
David Morris United States	8	102 0.9×	68 0.6×	9 0.1×	65 1.4×	13 0.3×	25	224
Shibiao Sang China	10	89 0.8×	137 1.3×	156 1.9×	15 0.3×	31 0.7×	35	280

Countries citing papers authored by Stephen Jay Frank

Since Specialization

Citations

This map shows the geographic impact of Stephen Jay Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Jay Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Jay Frank more than expected).

Fields of papers citing papers by Stephen Jay Frank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Jay Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Jay Frank. The network helps show where Stephen Jay Frank may publish in the future.

Co-authorship network of co-authors of Stephen Jay Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Jay Frank. A scholar is included among the top collaborators of Stephen Jay Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Jay Frank. Stephen Jay Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hajaj, Emma, Shiri Klein, Sharon Merims, et al.. (2020). Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study. Frontiers in Oncology. 10. 70–70. 30 indexed citations

2.

Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2019). Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases. The Prostate. 79(14). 1683–1691. 16 indexed citations

3.

Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2018). Radium-223 retreatment in an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases: 2-year follow-up.. Journal of Clinical Oncology. 36(6_suppl). 178–178. 1 indexed citations

4.

Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2017). Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases. Annals of Oncology. 28(10). 2464–2471. 21 indexed citations

5.

Cohen, Jonathan, et al.. (2017). Adoptive Cell Therapy: Past, Present and Future. Immunotherapy. 9(2). 183–196. 32 indexed citations

6.

Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2016). Radium-223 re-treatment from an international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases. Annals of Oncology. 27. vi255–vi255. 1 indexed citations

7.

Procopio, Giuseppe, Stefano Severi, Elena Verzoni, et al.. (2016). Radium-223 (Ra-223) Re-treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC). Annals of Oncology. 27. iv30–iv30. 1 indexed citations

8.

Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2016). Re-treatment with radium-223: An international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases.. Journal of Clinical Oncology. 34(15_suppl). 5074–5074. 1 indexed citations

9.

Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2016). Radium-223 (Ra-223) re-treatment (Re-tx): First experience from an international, multicenter, prospective study in patients (Pts) with castration-resistant prostate cancer and bone metastases (mCRPC).. Journal of Clinical Oncology. 34(2_suppl). 197–197. 9 indexed citations

10.

Gofrit, Ofer N., Amichay Meirovitz, Dov Pode, et al.. (2014). Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: A case-control study. Urologic Oncology Seminars and Original Investigations. 33(1). 19.e1–19.e5. 36 indexed citations

11.

Sfoungaristos, Stavros, Stephen Jay Frank, Mordechai Duvdevani, et al.. (2014). Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer. Expert Opinion on Pharmacotherapy. 15(17). 2513–2524. 1 indexed citations

12.

Sella, Avishay, Tal Sella, Avivit Peer, et al.. (2014). Activity of Cabazitaxel After Docetaxel and Abiraterone Acetate Therapy in Patients With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 12(6). 428–432. 29 indexed citations

13.

Sella, Avishay, Tal Sella, Avivit Peer, et al.. (2013). Activity of cabazitaxel following docetaxel and abiraterone acetate in patients with castration-resistant prostate cancer.. Journal of Clinical Oncology. 31(15_suppl). e16023–e16023. 8 indexed citations

14.

Sella, Avishay, Tal Sella, Avivit Peer, et al.. (2013). Activity of cabazitaxel following docetaxel and abiraterone acetate in patients with castration-resistant prostate cancer.. Journal of Clinical Oncology. 31(6_suppl). 186–186. 4 indexed citations

15.

Gunn, G. Brandon, Tito R. Mendoza, Adam S. Garden, et al.. (2011). Patient-reported fatigue in head and neck cancer survivors.. Journal of Clinical Oncology. 29(15_suppl). 5523–5523. 3 indexed citations

16.

Rosenthal, David I., G. Brandon Gunn, Tito R. Mendoza, et al.. (2011). Long-term symptom burden after radiation treatment for oropharynx cancer: A comparison of 3D and IMRT techniques.. Journal of Clinical Oncology. 29(15_suppl). 5539–5539.

17.

Chopra, Shefali, Stephen Jay Frank, & Mai Gu. (2010). Cytologic Diagnosis of Chordoma in a Peritoneal Effusion. Acta Cytologica. 54(3). 341–344. 3 indexed citations

18.

Badr, Hoda, David I. Rosenthal, Kathrin Milbury, et al.. (2010). Do the treatment outcome priorities of head and neck cancer patients change after undergoing radiation treatment?. Journal of Clinical Oncology. 28(15_suppl). 5599–5599. 2 indexed citations

19.

Gunn, G. Brandon, Tito R. Mendoza, Adam S. Garden, et al.. (2010). The relationship of presenting symptom burden and survival in patients with head and neck cancer (HNC).. Journal of Clinical Oncology. 28(15_suppl). 5600–5600. 1 indexed citations

20.

Frank, Stephen Jay, S. Specter, A. Nowotny, & Herman Friedman. (1980). Effect of Immune Sera upon Enhanced in Vitro Antibody Responses. Advances in experimental medicine and biology. 121B. 261–267. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact